2,3-dinor-thromboxane b2 has been researched along with Cancer of the Uterus in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aitokallio-Tallberg, AM; Jung, JK; Kim, SJ; Viinikka, LU; Ylikorkala, RO | 1 |
1 other study(ies) available for 2,3-dinor-thromboxane b2 and Cancer of the Uterus
| Article | Year |
|---|---|
Urinary excretion of degradation products of prostacyclin and thromboxane is increased in patients with gestational choriocarcinoma.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Biomarkers, Tumor; Choriocarcinoma; Epoprostenol; Female; Humans; Pregnancy; Reference Values; Thromboxane A2; Thromboxane B2; Uterine Neoplasms | 1991 |